New Recruiting Trial: Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome
WHY IT MATTERS
If H. pylori is found to worsen insulin resistance in metabolic syndrome patients, treating the infection could become a new way to help manage this common condition that affects millions of people.
Researchers are looking for people with metabolic syndrome (a group of conditions including high blood pressure, blood sugar, and cholesterol) to study whether a common stomach bacteria called H. pylori might make insulin resistance worse. Insulin resistance means your body has trouble using a hormone called insulin that controls blood sugar. The study will help doctors understand if treating this bacteria could help people with metabolic syndrome feel better.
NCT ID: NCT07501858 Title: Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome Status: RECRUITING Sponsor: Center of New Medical Technologies Start date: 2026-04-01 URL: https://clinicaltrials.gov/study/NCT07501858 Source: UniteRare clinical trials database
ASK YOUR DOCTOR
If you have metabolic syndrome and are interested in participating, ask your doctor whether you might be eligible for this trial starting in April 2026, or visit clinicaltrials.gov/study/NCT07501858 to check enrollment locations near you.